low FODMAP
Dietary Supplementconsumed EN formula containing low FODMAPs (0.320g/can) during 14-day intervention
NCT Number: NCT02353689
This study aimed to investigate the effects of FODMAP contents in enteral nutrition (EN) formulas on major gastrointestinal intolerance symptoms and nutritional status in tube fed patients through the randomized, double blind and placebo-controlled trial.
Looking for future studies?
Notify Me20 year–90 year
All sexes
Interventional
Phase 2 / Phase 3
A randomized, double-blind, placebo-controlled study was conducted on 100 tube-fed patients. Over a 14-day test period, the test group consumed EN formula containing low FODMAPs, while the placebo groups consumed EN formula containing moderate or high FODMAPs .
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
consumed EN formula containing low FODMAPs (0.320g/can) during 14-day intervention
consumed EN formula containing moderate FODMAPs (0.753g/can) during 14-day intervention
consumed EN formula containing high FODMAPs (1.222g/can) during 14-day intervention
Time frame: 14-day follow-up
Time frame: 14-day follow-up
Time frame: 14-day follow-up
Oh Yoen Kim
Other
Identification of the Effect of Fermentable Oligo-, di-, and Mono- Saccharides and Poorly Absorbed Short-chain Carbohydrate (FODMAP) Content in Tube Feeding Formula on Feeding Intolerance and Nutritional Status Improvement
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07437352
Enteral Nutrition, Frailty
Ancona, Italy
View Trial DetailsNCT07131098
Critical Illness, Disease Attributes
Jenin, Palestinian Territories
View Trial DetailsNCT06239610
Enteral Nutrition
Fort Wayne, Indiana, United States
View Trial DetailsNCT07018414
Abdominal Distension, Critical Illness
Istanbul, İ̇stanbul, Turkey (Türkiye)
View Trial Details